icon-folder.gif   Conference Reports for NATAP  
 
  EASL 44th Annual Meeting
April 22-26, 2009
Copenhagen, Denmark
Back grey_arrow_rt.gif
 
 
 
EFFICACY AND SAFETY OF THE CYCLOPHILIN INHIBITOR DEBIO 025 IN COMBINATION WITH PEGYLATED INTERFERON ALPHA-2A AND RIBAVIRIN IN PREVIOUSLY NULL-RESPONDER GENOTYPE 1 HCV PATIENTS
 
 
  Reported by Jules Levin
EASL April 23-26 2009-04-30
Copenhagen, Denmark
 
D.R. Nelson, R.H. Ghalib, M. Sulkowski, E. Schiff, V. Rustgi, P.J. Pockros, C. Wang, G. Decosterd, P. Grosgurin , H. Porchet, R. Crabbe

debio-1.gif

backGround-2.gif

HCV-3.gif

aims-4.gif

AgeMean-5.gif

load-6.gif

trough-7.gif

SD-8.gif

PegIfn-9.gif

nWith-10.gif

RBV-11.gif

adverse-12.gif

MRP-13.gif

Treatmnt-14.gif